Month: March 2022
Expects to add two U.S. Food and Drug Administration (“FDA”)-approved, new chemical entities (“NCEs”) with patent life into 2031 and expand acute care footprint
Commercialized assets, BARHEMSYS® (amisulpride for injection) and BYFAVO® (remimazolam for injection), represent a strong strategic fit with Eagle’s specialized hospital-based salesforce
Addressable market for the two products combined is estimated to be $3.1 billion per year1
Anticipates significant financial synergies from the proposed transaction
Company to hold investor conference call to discuss proposed transaction on Thursday, March 31, 2022, at 8:30am ETWOODCLIFF LAKE, N.J., March 28, 2022 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced it has reached agreement on the terms of a transfer of the entire issued...
Functional Protein Market to Worth USD 15.98 Billion by (2021-2028) | Functional Protein Industry CAGR of 14.48%
Written by Customer Service on . Posted in Mergers And Acquisitions.
Companies covered in functional protein market are DuPont Nutrition (U.S.), Essentia Protein Solutions (U.S.), Glanbia plc (Ireland), ProtiFarm (Netherlands), ADM (U.S.), AMCO Proteins (U.S.), DSM (Netherlands), Merit Functional Foods (Canada), Plantible Foods (U.S.), Roquette Frères (France) and more players profiled
Pune, India, March 28, 2022 (GLOBE NEWSWIRE) — The global functional protein market is expected to rise in the coming years, owing to the increasing demand for plant-based proteins and awareness about healthy dietary supplement consumption. Fortune Business Insights™ publishes this information in a report titled, “Functional Protein Market, 2021-2028”. As per the report, the functional protein market size was USD 5.24 billion in 2020. The market size is expected to rise from USD 6.20 billion in 2021 to...
Sydbank share buyback programme: transactions in week 12
Written by Customer Service on . Posted in Public Companies.
Company Announcement No 11/2022Peberlyk 46200 AabenraaDenmark
Tel +45 74 37 37 37Fax +45 74 37 35 36
Sydbank A/SCVR No DK 12626509, Aabenraasydbank.dk28 March 2022
Dear Sirs
Sydbank share buyback programme: transactions in week 12On 2 March 2022 Sydbank announced a share buyback programme of DKK 425m. The share buyback commenced on 7 March 2022 and will be completed by 30 December 2022.
The purpose of the share buyback programme is to reduce the share capital of Sydbank and the programme is executed in compliance with the provisions of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, collectively referred to as the Safe Harbour rules.
The following transactions have been made under the share buyback programme:
Number...
CLEAN MOTION ON RE:VOLT – COLLABORATION PROJECTS IN FULL SWING. THE ORDER OPENS THIS SUMMER.
Written by Customer Service on . Posted in Public Companies.
Revolt solar chargedClean Motion has now started a total of six collaboration projects for optimization of Re:volt. The work on the projects has begun, and the goal is to roll out the first commercial pilot fleets during the coming fall. Another four projects will start in the spring. The projects cover most of the typical uses-cases of urban transport and together they will contribute to a complete customer offering for the European market. The ordering of Re:volt opens this summer.
During the fall of 2021, Clean Motion had dialogues with many companies in the last-mile segment. The purpose has been to find relevant partners to optimize and complete final versions of Re:volt to suit different uses-cases. Several of these partners are now in place, and the work is underway. The selected companies operate in retail, food deliveries,...
Proactive news headlines including Gascoyne Resources, Tempest Minerals, Silver Mines and DomaCom Australia
Written by Customer Service on . Posted in Mergers And Acquisitions.
Sydney, March 28, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Gascoyne Resources Ltd (ASX:GCY) is undertaking a capital raising of up to $19 million to underpin the next phase of a near-mine exploration and production growth strategy at the 100%-owned Dalgaranga Gold Mine in Western Australia. Click here
Tempest Minerals Ltd (ASX:TEM) has soared on a new copper discovery described as “spectacular” that was uncovered during a drill program at the Orion target, part of the company’s flagship Meleya Project in Western Australia. Click here
Silver Mines Ltd (ASX:SVL) has intersected visible gold for the first time ever during an underground resource drilling program at the Bowdens Silver Project near Mudgee...
Jyseleca® approved in Japan for ulcerative colitis
Written by Customer Service on . Posted in Public Companies.
Approval of additional indication based on Phase 2b/3 SELECTION study in patients with moderate-to-severe ulcerative colitis
Mechelen, Belgium; 28 March 2022, 08.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) reports that Gilead Sciences K.K. (Tokyo, Japan), Eisai Co., Ltd. (Tokyo, Japan) and EA Pharma Co., Ltd. (Tokyo, Japan) today announced the approval by the Japanese Ministry of Health, Labour and Welfare (MHLW), of a second indication for Jyseleca (filgotinib), a once-daily, oral, JAK1 preferential inhibitor, for the treatment of patients with moderate-to-severe active ulcerative colitis (UC).
The approval of this second indication for Jyseleca in Japan is based on data from the randomized, double-blind, placebo-controlled phase 2b/3 SELECTION study. This study evaluated the efficacy and safety of Jyseleca for induction and maintenance...
Cornish Metals to Raise Up to £40.5 Million Through a £25 Million Strategic Investment by Sir Mick Davis’ Vision Blue Resources and a UK Placing and Canadian Subscription of Up to £15.5 Million
Written by Customer Service on . Posted in Public Companies.
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, THE REPUBLIC OF SOUTH AFRICA, NEW ZEALAND OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BREACH ANY APPLICABLE LAW OR REGULATION.
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES IN CORNISH METALS INC OR ANY OTHER ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT OF ITS DISTRIBUTION, SHALL FORM THE BASIS OF, OR BE RELIED ON IN CONNECTION WITH ANY INVESTMENT DECISION IN RESPECT OF CORNISH METALS...
Offer by Eagle Pharmaceuticals, Inc.
Written by Customer Service on . Posted in Mergers And Acquisitions.
ACACIA PHARMA GROUP PLC
PROPOSED TRANSACTION WITH EAGLE PHARMACEUTICALS, INC.
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION AND INSIDE INFORMATION
Not for release, publication or distribution, in whole or in part, directly or indirectly in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction
For immediate release
28 March 2022, 08:00 a.m. (Brussels time)
RECOMMENDED SCHEME OF ARRANGEMENT
of
ACACIA PHARMA GROUP PLC
by
EAGLE PHARMACEUTICALS, INC.
to be effected by means of a Scheme of Arrangement under Part 26 of the Companies Act 2006
Summary
This summary should be read in conjunction with, and is subject to, the full text of the following announcement (including its Appendices).
Key highlightsAcacia Pharma Group PLC (“Acacia”) met its formulary goals for both Barhemsys®...
Dékuple : Strong earnings growth for 2021
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
STRONG EARNINGS GROWTH FOR 2021Net sales: €164.3m (+18%)
Gross margin: €134.6m (+13%)
EBITDA: €20.3m (+39%), representing 15.1% of the gross margin
Consolidated net income: €9.1m (+47%)
Proposed dividend of €0.88 per share
“Ambition 2025”: becoming a European leader for data marketingParis, 28 March 2022 (8:00am) – The DÉKUPLE Group, a cross-channel data marketing expert, is reporting its full-year earnings for 2021.
Bertrand Laurioz, DÉKUPLE Group Chairman and CEO: “Despite the constraints with the health crisis, 2021 was an outstanding year of growth and transformation for our Group. Driven by the growth in our digital marketing and insurance activities, our net sales climbed 18% to €164.3m. Supported by our robust management, our consolidated net income recorded sustained growth, up 47% to €9.1m.
These good results once...
ASM INTERNATIONAL UNVEILS EXPANSION IN SINGAPORE TO MEET GLOBAL CUSTOMER DEMAND FOR ADVANCED SEMICONDUCTORS
Written by Customer Service on . Posted in Public Companies.
Singapore,March 28, 2022
ASM International N.V. (Euronext Amsterdam: ASM) officially unveiled its state-of-the-art Singapore manufacturing facility and operations hub today and announced the groundbreaking of a second manufacturing floor at the site. The opening ceremony was attended by Singapore Minister for Manpower and Second Minister for Trade and Industry, Dr Tan See Leng, and by representatives of JTC Corporation and of the Singapore Economic Development Board.
ASM’s Singapore expansion comes amidst recent global chip shortages, and will enable ASM to capitalize on surging demand brought on by accelerated digitalization trends. The facility, including the first manufacturing floor, was completed at the end of 2020. Including the second manufacturing floor, that will be production-ready early 2023, ASM’s capacity in Singapore will...
